- Home
- ALLO vs OLP Comparison
ALLO vs OLP Comparison
Compare ALLO & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLO | OLP |
|---|---|---|
| Founded | 2017 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 471.5M |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALLO | OLP |
|---|---|---|
| Price | $1.22 | $22.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $9.00 | ★ $27.17 |
| AVG Volume (30 Days) | ★ 5.2M | 76.7K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 8.30% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | ★ $82,740,000.00 |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | $255.46 | $1.95 |
| P/E Ratio | ★ N/A | $21.65 |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $1.04 | $19.62 |
| 52 Week High | $4.46 | $25.88 |
Technical Indicators
Market Signals| Indicator | ALLO | OLP |
|---|---|---|
| Relative Strength Index (RSI) | 24.71 | 51.60 |
| Support Level | N/A | $22.36 |
| Resistance Level | $2.22 | $23.63 |
| Average True Range (ATR) | 0.08 | 0.42 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 0.00 | 96.73 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred and two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.